Short Information | Palatin Technologies Inc. (NYSE:PTN)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 21,337 |
Total Actual Volume | 1,468,672 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 1,067 |
Average Short Percentage | 1.57% |
Is there a PTN Short Squeeze or Breakout about to happen?
See the PTN Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-22-2024 | $1.73 | $1.73 | $1.79 | $1.7 | 106,427 | 454 | 0.43% |
07-19-2024 | $1.73 | $1.73 | $1.77 | $1.68 | 55,905 | 1,550 | 2.77% |
07-18-2024 | $1.8 | $1.71 | $1.847 | $1.7 | 69,442 | 143 | 0.21% |
07-17-2024 | $1.81 | $1.81 | $1.86 | $1.77 | 54,459 | 928 | 1.7% |
07-16-2024 | $1.8 | $1.82 | $1.8899 | $1.78 | 70,803 | 449 | 0.63% |
07-15-2024 | $1.82 | $1.83 | $1.87 | $1.75 | 88,615 | 108 | 0.12% |
07-12-2024 | $1.74 | $1.77 | $1.8 | $1.73 | 51,600 | 489 | 0.95% |
07-11-2024 | $1.75 | $1.76 | $1.8 | $1.71 | 71,869 | 136 | 0.19% |
07-10-2024 | $1.71 | $1.71 | $1.79 | $1.7 | 84,871 | 1,380 | 1.63% |
07-09-2024 | $1.83 | $1.77 | $1.83 | $1.7399 | 66,420 | 133 | 0.2% |
07-08-2024 | $1.82 | $1.78 | $1.84 | $1.74 | 64,099 | 2,129 | 3.32% |
07-05-2024 | $1.82 | $1.8 | $1.84 | $1.76 | 82,532 | 598 | 0.72% |
07-03-2024 | $1.88 | $1.76 | $1.96 | $1.76 | 94,079 | 161 | 0.17% |
07-02-2024 | $1.89 | $1.88 | $1.9 | $1.8 | 70,895 | 8,800 | 12.41% |
07-01-2024 | $1.94 | $1.86 | $1.98 | $1.84 | 107,305 | 1,403 | 1.31% |
06-28-2024 | $1.93 | $1.95 | $1.97 | $1.83 | 119,810 | 454 | 0.38% |
06-27-2024 | $1.83 | $1.9 | $1.92 | $1.81 | 60,302 | 294 | 0.49% |
06-26-2024 | $1.78 | $1.82 | $1.84 | $1.78 | 38,056 | 703 | 1.85% |
06-25-2024 | $1.81 | $1.81 | $1.8699 | $1.8 | 35,707 | 334 | 0.94% |
06-24-2024 | $1.86 | $1.82 | $1.92 | $1.81 | 75,476 | 691 | 0.92% |
News, Short Squeeze, Breakout and More Instantly...
Palatin Technologies Inc. Company Name:
PTN Stock Symbol:
NYSE Market:
Palatin Technologies Inc. Website:
Palatin Announces Exercise of Warrants for Approximately $6.1 Million Gross Proceeds PR Newswire CRANBURY, N.J. , June 21, 2024 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) ("Palatin" or the "Company"), a biopharmaceutical company developing fi...
Palatin Announces the Initiation of a Phase 2 Clinical Study of Bremelanotide Co-Administered with a PDE5i for the Treatment of Erectile Dysfunction (ED) PR Newswire In ED patients that do not respond to PDE5i monotherapy ~30-40% of ED patients do not respond to PDE5...
Palatin Initiates Phase 2 Clinical Study of Bremelanotide for the Treatment of Obesity PR Newswire Co-Administration Phase 2 study of bremelanotide with tirzepatide (GLP-1) to provide key information for melanocortin treatments of obesity Topline data expected by end...